TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
6/20/24 07:30 | 6/17/24 | BHVN | Biohaven Ltd. | D8 | Health | Drug | Pharmaceutical Preparations | Car Bruce | CT | O | Chief Sc | P | 1,007 | 33.58 | 0 | 30 | 999% | 32 | I | ||||||||||||||
2/23/22 16:11 | 2/18/22 | AGIO | Agios Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Car Bruce | MA | O | Chief Sc | M.d | 0 | 0.00 | 0 | 7 | 70 | 17 | D | ||||||||||||||
2/14/22 16:07 | 2/10/22 | AGIO | Agios Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Car Bruce | MA | O | Chief Sc | M.d | 0 | 0.00 | 0 | 4 | 44 | 12 | D | ||||||||||||||
1/10/22 16:06 | 1/6/22 | AGIO | Agios Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Car Bruce | MA | O | Chief Sc | M.d | 0 | 0.00 | 0 | 3 | 58 | 9 | D | ||||||||||||||
4/15/21 16:46 | 1/6/21 | AGIO | Agios Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Car Bruce | MA | O | Chief Sc | M.d | 0 | 0.00 | 0 | 3 | 94 | 7 | D | ||||||||||||||
4/15/20 16:25 | 4/13/20 | AGIO | Agios Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Car Bruce | MA | O | Chief Sc | M.d | 0 | 0.00 | 0 | 7 | 5 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |